TY - JOUR
T1 - Habitual intake of dietary flavonoids and risk of Parkinson disease
AU - Gao, X.
AU - Cassidy, A.
AU - Schwarzschild, M. A.
AU - Rimm, E. B.
AU - Ascherio, A.
N1 - Funding Information:
Dr. Gao serves on the Committee on Nutrition, Trauma, and the Brain, Institute of Medicine; has received research support from the NIH/NINDS; and has served as a consultant for Teva Pharmaceutical Industries Ltd. Dr. Cassidy has received research support from Unilever and Diabetes UK. Dr. Schwarzschild has received research support from the NIH/NINDS, the US Department of Defense, the Michael J. Fox Foundation, the Parkinson Disease Foundation, the RJG Parkinson's Disease Foundation, the American Parkinson Disease Association, and the American Federation for Aging Research. Dr Rimm serves on the editorial boards of American Journal of Clinical Nutrition and American Journal of Epidemiology ; and receives research support from the NIH. Dr. Ascherio serves on a scientific advisory board for the Michael J. Fox Foundation; serves as Associate Editor for Multiple Sclerosis and Related Disorders and the Journal of Parkinson Disease and on the editorial boards of Neurology ® and Annals of Neurology ; has received speaker honoraria from Merck Serono; and receives research support from the NIH, the US Department of Defense, the Michael J. Fox Foundation, and the National Multiple Sclerosis Society.
PY - 2012/4/10
Y1 - 2012/4/10
N2 - Objective: To prospectively examine whether higher intakes of total flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) were associated with a lower risk of developing Parkinson disease (PD). Methods: In the current analysis, we included 49,281 men in the Health Professional Follow-up Study and 80,336 women from the Nurses' Health Study. Five major sources of flavonoid-rich foods (tea, berry fruits, apples, red wine, and orange/orange juice) were also examined. Flavonoid intake was assessed using an updated food composition database and a validated food frequency questionnaire. Results: We identified 805 participants (438 men and 367 women) who developed PD during 20-22 years of follow-up. In men, after adjusting for multiple confounders, participants in the highest quintile of total flavonoids had a 40% lower PD risk than those in the lowest quintile (hazard ratio [HR] = 0.60; 95% confidence interval 0.43, 0.83; p trend = 0.001). No significant relationship was observed in women (p trend = 0.62) or in pooled analyses (p trend = 0.23). In the pooled analyses for the subclasses, intakes of anthocyanins and a rich dietary source, berries, were significantly associated with a lower PD risk (HR comparing 2 extreme intake quintiles were 0.76 for anthocyanins and 0.77 for berries, respectively; p trend < 0.02 for both). Conclusions: Our findings suggest that intake of some flavonoids may reduce PD risk, particularly in men, but a protective effect of other constituents of plant foods cannot be excluded.
AB - Objective: To prospectively examine whether higher intakes of total flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) were associated with a lower risk of developing Parkinson disease (PD). Methods: In the current analysis, we included 49,281 men in the Health Professional Follow-up Study and 80,336 women from the Nurses' Health Study. Five major sources of flavonoid-rich foods (tea, berry fruits, apples, red wine, and orange/orange juice) were also examined. Flavonoid intake was assessed using an updated food composition database and a validated food frequency questionnaire. Results: We identified 805 participants (438 men and 367 women) who developed PD during 20-22 years of follow-up. In men, after adjusting for multiple confounders, participants in the highest quintile of total flavonoids had a 40% lower PD risk than those in the lowest quintile (hazard ratio [HR] = 0.60; 95% confidence interval 0.43, 0.83; p trend = 0.001). No significant relationship was observed in women (p trend = 0.62) or in pooled analyses (p trend = 0.23). In the pooled analyses for the subclasses, intakes of anthocyanins and a rich dietary source, berries, were significantly associated with a lower PD risk (HR comparing 2 extreme intake quintiles were 0.76 for anthocyanins and 0.77 for berries, respectively; p trend < 0.02 for both). Conclusions: Our findings suggest that intake of some flavonoids may reduce PD risk, particularly in men, but a protective effect of other constituents of plant foods cannot be excluded.
UR - http://www.scopus.com/inward/record.url?scp=84860708402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860708402&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e31824f7fc4
DO - 10.1212/WNL.0b013e31824f7fc4
M3 - Article
C2 - 22491871
AN - SCOPUS:84860708402
SN - 0028-3878
VL - 78
SP - 1138
EP - 1145
JO - Neurology
JF - Neurology
IS - 15
ER -